Top news of the week: 25.08.2020.
Vaccination, Biotechnology, Malaria, Contract research organization, NASDAQ, Breast implant
Healthcare
The rejection of $BMRN's gene therapy fo hemophilia was "a sad day," one patient tells @cooney_liz. “It’s also a good day, because I think this community has fought long and hard for safety to be a priority.”
https://t.co/VFJBrefwYt via @statnews
OpenWary hemophilia patients say they’re willing to wait longer for a safe gene therapy
For one family active in the hemophilia patient community, the FDA rejection of BioMarin's gene therapy was disappointing, but also appreciated.
Pfizer-BioNTech Vaccine Data, Sorrento To Buy R&D Partner, Kymera IPO #BioTech via https://t.co/2sI0UxJbpn https://t.co/nzVztcCg3i
OpenThe Daily Biotech Pulse: Pfizer-BioNTech Vaccine Data, Sorrento To Buy R&D Partner, Kymera IPO
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 20) 10X Genomics Inc (NASDAQ: TXG) Avenue Therapeutics Inc (NASDAQ: ATXI) Cardiff Oncology Inc (NASDAQ: CRDF)...
CDMO M&As Eclipse CROs' as Investors Focus on Fundamentals Amidst COVID-19 https://t.co/toToud1I3x https://t.co/cEephltayc
OpenCDMO M&As Eclipse CROs’ as Investors Focus on Fundamentals Amidst COVID-19
Pharmaceutical industry investors are betting on contract development and manufacturing organizations (CDMOs) this year, as they shift their focus from contract research organizations (CRO).
Bharat Biotech gets approval to test COVAXIN administration through skin #BioTech via https://t.co/2sI0UxJbpn https://t.co/NzgRFOQhfW
OpenBharat Biotech gets approval to test COVAXIN administration through skin
The Drug Controller General of India has given its approval to Bharat Biotech to conduct clinical trials for the COVID-19 vaccine candidate COVAXIN through intradermal vaccine delivery
Bharat Biotech wants to test administering Covid vaccine through skin instead of muscle #BioTech via https://t.co/2sI0UxJbpn https://t.co/sX5uemFPZC
OpenBharat Biotech wants to test administering Covid vaccine through skin instead of muscle
Intradermal vaccine delivery, if proven effective, could make Covaxin shots cheaper since they require a lesser amount of vaccine, which also means more people can get vaccinated.
Join @JanssenUS and @JLABS for an in-depth look into the process of filing a small or large molecule IND, including strategies for CMC, non-clinical safety assessment, designing First-in-Human trials and regulatory considerations. Register: https://t.co/tgMOniLmSs https://t.co/S7O4QF1rw5
OpenGot a Plan? Your Guide to Filing a Large or Small Molecule IND
Overview description goes here. If your webinar is a rebroadcast of a recording, please insert/edit this text:*Please note: This webinar will be a rebroadcast of the recording which took ...
Good to hear: Marks told Reuters he has not faced any political pressure and that the FDA would be guided by science alone. Should that change, "I could not stand by and see something that was unsafe or ineffective that was being put through," https://t.co/xoCCmgCpeY
OpenExclusive: Top FDA official says would resign if agency rubber-stamps an unproven COVID-19 vaccine
A top U.S. health regulator who will help decide the fate of a coronavirus vaccine has vowed to resign if the Trump administration approves a vaccine before it is shown to be safe and ...
FDA reports new cases of cancer, illnesses linked to breast implants #BioTech via https://t.co/2sI0UxJbpn https://t.co/GHtYs7YKgx
OpenFDA reports new cases of cancer, illnesses linked to breast implants
As part of its safety surveillance efforts, the FDA has published new data on harmful side effects associated with breast implants, including certain cases of cancer as well as what ...